Make it a Bit Fuzzy

De-identification methods help reduce the risk that patients whose information is housed in a database can be re-identified, according to a new study.

Researchers from the Cancer Registry of Norway applied both k-anonymization and a fuzzy factor to a set of nearly 5.7 million records from more than 911,000 women in the Norwegian Cervical Cancer Screening Program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.